Founded in Switzerland in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.
ObsEva is led by a strong management team with substantial experience in successfully developing and commercializing pharmaceutical products in our target market. ObsEva’s team members include trained obstetricians and gynecologists with an in-depth understanding of patient and physician needs. Our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.Company Corporate presentation
Are you ready to join an innovative biopharmaceutical company that’s advancing women’s reproductive health and pregnancy therapeutics?
Check out our vacancies and/or register to our talent community by clicking on the link below.
We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.Continue to link
Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.Continue